Selective, orally active leukotriene D4 (LTD4) antagonist; inhibits binding of [3H]-LTD4 to guinea pig lung membranes (Ki = 0.63 μM). Acts as an agonist at peroxisome proliferator-activated receptors (PPARs).
|Storage||Store at +4°C|
The technical data provided above is for guidance only. For batch specific data refer to the Certificate of Analysis.
All Tocris products are intended for laboratory research use only.
References are publications that support the biological activity of the product.
Fleisch et al (1985) LY171883, 1-less than 2-hydroxy-3-propyl-4-less than 4-(1H-tetrazol-5-yl) butoxy greater than phenyl greater than ethanone, an orally active leukotriene D4 antagonist. J.Pharmacol.Exp.Ther. 233 148 PMID: 3981452
Aharony et al (1987) Inhibition of 3H-leukotriene D4 binding to guinea pig lung receptors by the novel leukotriene antagonist ICI 198,615. J.Pharmacol.Exp.Ther. 243 921 PMID: 2826761
Cannon and Eacho (1991) Interaction of LY171883 and other peroxisome proliferators with fatty-acid-binding protein isolated from rat liver. Biochem.J. 280 387 PMID: 1747111
View Related Products by Target
View Related Products by Product Action
Keywords: LY 171883, LY 171883 supplier, Selective, orally, active, LTD4, antagonists, CysLT1, Receptors, LY171883, Tomelukast, Leukotriene, and, Related, 2140, Tocris Bioscience
Citations for LY 171883
Citations are publications that use Tocris products.
Currently there are no citations for LY 171883.
Reviews for LY 171883
There are currently no reviews for this product. Be the first to review LY 171883 and earn rewards!
Have you used LY 171883?
Submit a review and receive an Amazon gift card.
$10US/$10CAN/€7/£6 gift card for a review without an image
$25US/$25CAN/€18/£15 gift card for a review with an image
*Offer only valid in the USA / Canada, UK and EuropeSubmit a Review
Literature in this Area
Tocris offers the following scientific literature in this area to showcase our products. We invite you to request* or download your copy today!
*Please note that Tocris will only send literature to established scientific business / institute addresses.